These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 6494190)
1. Studies in vivo and in vitro on N-acetylphenelzine. Danielson TJ; Coutts RT; Baker GB; Rubens M Proc West Pharmacol Soc; 1984; 27():507-10. PubMed ID: 6494190 [No Abstract] [Full Text] [Related]
2. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat. Coutts RT; Mozayani A; Danielson TJ; Baker GB J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538 [TBL] [Abstract][Full Text] [Related]
4. Potential prodrugs of phenelzine: N2-acetylphenelzine and N2-ethoxycarbonylphenelzine. Danielson TJ; Coutts RT; Baker GB; Chan MC J Pharm Sci; 1988 Jun; 77(6):498-9. PubMed ID: 3171928 [TBL] [Abstract][Full Text] [Related]
5. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Paslawski T; Treit D; Baker GB; George M; Coutts RT Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939 [TBL] [Abstract][Full Text] [Related]
6. [Heterocyclic amine derivatives - analogs of mebanazine, pheniprazine and phenelzine. II. Studies on the effect, on the central nervous system, of derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine, perhydro-1,5-oxazocine and morpholine-containing arylalkyloamine groups]. Szadowska A; Mazur M; Szmigielski A; Szmigielska H; Winer A Acta Pol Pharm; 1983; 40(1):111-8. PubMed ID: 6136156 [No Abstract] [Full Text] [Related]
7. Recent studies on the MAO inhibitor phenelzine and its possible metabolites. McKenna KF; Baker GB; Coutts RT; Rauw G; Mozayani A; Danielson TJ J Neural Transm Suppl; 1990; 32():113-8. PubMed ID: 1982447 [TBL] [Abstract][Full Text] [Related]
8. Metabolic acetylation of phenelzine in rats. Mozayani A; Coutts RT; Danielson TJ; Baker GB Res Commun Chem Pathol Pharmacol; 1988 Dec; 62(3):397-406. PubMed ID: 3222522 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of acyl derivatives of phenelzine. Coutts RT; Mozayani A; Pasutto FM; Baker GB; Danielson TJ Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):3-15. PubMed ID: 2326546 [TBL] [Abstract][Full Text] [Related]
10. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. Wooters TE; Bardo MT Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo. Green AL; el Hait MA J Pharm Pharmacol; 1978 Apr; 30(4):262-3. PubMed ID: 24723 [No Abstract] [Full Text] [Related]
12. Synthesis of N-propargylphenelzine and analogues as neuroprotective agents. Ling L; Urichuk LJ; Sloley BD; Coutts RT; Baker GB; Shan JJ; Pang PK Bioorg Med Chem Lett; 2001 Oct; 11(20):2715-7. PubMed ID: 11591508 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response. Heydendael W; Jacobson L Brain Res; 2008 Oct; 1238():93-107. PubMed ID: 18761333 [TBL] [Abstract][Full Text] [Related]
16. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro. Panova NG; Axenova LN; Medvedev AE Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512 [TBL] [Abstract][Full Text] [Related]
17. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. Merikangas KR; Merikangas JR Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662 [TBL] [Abstract][Full Text] [Related]
18. Antidepressant phenelzine alters differentiation of cultured human and mouse preadipocytes. Chiche F; Le Guillou M; Chétrite G; Lasnier F; Dugail I; Carpéné C; Moldes M; Fève B Mol Pharmacol; 2009 May; 75(5):1052-61. PubMed ID: 19201819 [TBL] [Abstract][Full Text] [Related]
19. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors]. Maki Y Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866 [TBL] [Abstract][Full Text] [Related]
20. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile. Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]